Serina Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2017 | 88.0% | -474.6% | -468.7% |
| FY2018 | 73.9% | -805.5% | -537.4% |
| FY2019 | 85.9% | -726.8% | -703.4% |
| FY2020 | 92.8% | -2,797.8% | -3,009.7% |
| FY2021 | 86.8% | -5,509.0% | -6,024.3% |
| FY2022 | 61.8% | -20,514.7% | -30,770.6% |
| FY2023 | 3.2% | -99.2% | 167.1% |
| FY2024 | — | -30,442.9% | -19,894.6% |
| FY2025 | — | -18,478.5% | -14,755.4% |